Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Collett

Showing results (1221-1230 of 1,249) with videos related to

Pageof 125
Sort By:
The Lancet. Oncology|December 19, 2018
Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trialGraham H Jackson, Faith E Davies, Charlotte Pawlyn, et al.
Blood Cancer Journal|December 10, 2016
Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trialJ R Jones, D A Cairns, W M Gregory, et al.
Diabetes Technology & Therapeutics|January 20, 2023
Rollout of Closed-Loop Technology to Pregnant Women with Type 1 Diabetes: Healthcare Professionals' Views About Potential Challenges and SolutionsDavid Rankin, Ruth I Hart, Barbara Kimbell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2012
Suppression of heat shock protein 27 induces long-term dormancy in human breast cancerOddbjørn Straume, Takeshi Shimamura, Michael J G Lampa, et al.
Frontiers in Neurology|September 28, 2020
Effect of Combined Therapy of Virtual Reality and Transcranial Direct Current Stimulation in Children and Adolescents With Cerebral Palsy: A Study Protocol for a Triple-Blinded Randomized Controlled Crossover TrialTalita Dias da Silva, Anne Michelli Gomes Gonçalves Fontes, Barbara Soares de Oliveira-Furlan, et al.
British Journal of Haematology|July 14, 2020
Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open-label, randomised, Phase III trialGraham H Jackson, Charlotte Pawlyn, David A Cairns, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|September 28, 2020
Environmental impacts of nitrogen emissions in China and the role of policies in emission reductionX J Liu, W Xu, E Z Du, et al.
Trials|January 9, 2020
Trial Forge Guidance 2: how to decide if a further Study Within A Trial (SWAT) is neededShaun Treweek, Simon Bevan, Peter Bower, et al.
The Lancet. Haematology|October 19, 2019
Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trialGraham H Jackson, Faith E Davies, Charlotte Pawlyn, et al.
Frontiers in Bioengineering and Biotechnology|April 26, 2021
Integration of Proteomics and Metabolomics Into the Design, Build, Test, Learn Cycle to Improve 3-Hydroxypropionic Acid Production in <i>Aspergillus pseudoterreus</i>Kyle R Pomraning, Ziyu Dai, Nathalie Munoz, et al.
Pageof 125

Showing results (1221-1230 of 1,249) with videos related to

Sort By:
Pageof 125
The Lancet. Oncology|December 19, 2018
Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trialGraham H Jackson, Faith E Davies, Charlotte Pawlyn, et al.
Blood Cancer Journal|December 10, 2016
Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trialJ R Jones, D A Cairns, W M Gregory, et al.
Diabetes Technology & Therapeutics|January 20, 2023
Rollout of Closed-Loop Technology to Pregnant Women with Type 1 Diabetes: Healthcare Professionals' Views About Potential Challenges and SolutionsDavid Rankin, Ruth I Hart, Barbara Kimbell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2012
Suppression of heat shock protein 27 induces long-term dormancy in human breast cancerOddbjørn Straume, Takeshi Shimamura, Michael J G Lampa, et al.
Frontiers in Neurology|September 28, 2020
Effect of Combined Therapy of Virtual Reality and Transcranial Direct Current Stimulation in Children and Adolescents With Cerebral Palsy: A Study Protocol for a Triple-Blinded Randomized Controlled Crossover TrialTalita Dias da Silva, Anne Michelli Gomes Gonçalves Fontes, Barbara Soares de Oliveira-Furlan, et al.
British Journal of Haematology|July 14, 2020
Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open-label, randomised, Phase III trialGraham H Jackson, Charlotte Pawlyn, David A Cairns, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|September 28, 2020
Environmental impacts of nitrogen emissions in China and the role of policies in emission reductionX J Liu, W Xu, E Z Du, et al.
Trials|January 9, 2020
Trial Forge Guidance 2: how to decide if a further Study Within A Trial (SWAT) is neededShaun Treweek, Simon Bevan, Peter Bower, et al.
The Lancet. Haematology|October 19, 2019
Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trialGraham H Jackson, Faith E Davies, Charlotte Pawlyn, et al.
Frontiers in Bioengineering and Biotechnology|April 26, 2021
Integration of Proteomics and Metabolomics Into the Design, Build, Test, Learn Cycle to Improve 3-Hydroxypropionic Acid Production in <i>Aspergillus pseudoterreus</i>Kyle R Pomraning, Ziyu Dai, Nathalie Munoz, et al.
Pageof 125